Table 3.
Echocardiographic data of study population according to fT3 concentration
| Characteristics | Group A Low fT3 < 3.10 pml/L (n = 9) |
Group B Normal fT3 ≥3.10 pmol/L (n = 50) |
p-value |
|---|---|---|---|
| LVEDD, mm | 65.5 (±12.7) | 65.6 (±9.9) | 0.9483 |
| LVESD, mm | 59.0 (±14.0) | 55.9 (±11.4) | 0.4692 |
| LVEDV, ml | 212.9 (±83.4) | 238.4 (±86.8) | 0.4187 |
| LVESV, ml | 178.8 (±76.3) | 184.6 (±78.9) | 0.8386 |
| SI | 0.6 (±0.07) | 0.64 (±0.12) | 0.3395 |
| LVEF, % | 16.1 (±5.7) | 25.4 (±7.4) | 0.0008 |
| MAPSE, mm | 4.0 (3.6–4.8) | 7.0 (5.0–8.9) | 0.0051 |
| E/A | 2.7 (2.2–3.2) | 1.3 (0.8–2.2) | 0.0082 |
| Number of pts. with restrictive mitral filling pattern, n (%) | 5 (8.3%) | 13 (46.4%) | 0.1801 |
| E/E’ | 15.2 (±5.6) | 17.5 (±8.5) | 0.4321 |
| RVSP, mmHg | 44.0 (39.0–62.5) | 35.0 (31.0–48.5) | 0.0794 |
| TAPSE, mm | 12.8 (±4.8) | 15.8 (±5.0) | 0.1066 |
| +dP/dt, mmHg/s | 466.0 (404.5–824.5) | 606.0 (457.0–757.0) | 0.4222 |
| Functional mitral regurgitation, n (%) | 5 (55.6%) | 21 (42.0%) | 0.4885 |